Brokerages expect that Constellium N.V. (NYSE:CSTM) will report $1.52 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Constellium’s earnings, with estimates ranging from $1.43 billion to $1.58 billion. Constellium reported sales of $1.25 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 21.6%. The firm is expected to report its next quarterly earnings report on Thursday, March 8th.
On average, analysts expect that Constellium will report full-year sales of $1.52 billion for the current fiscal year, with estimates ranging from $6.13 billion to $6.47 billion. For the next year, analysts anticipate that the business will post sales of $6.71 billion per share, with estimates ranging from $6.50 billion to $6.98 billion. Zacks’ sales calculations are a mean average based on a survey of research firms that follow Constellium.
Constellium (NYSE:CSTM) last released its earnings results on Thursday, October 26th. The industrial products company reported $0.23 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.05. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.36 billion. Constellium had a negative return on equity of 5.81% and a net margin of 0.61%. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share.
A number of hedge funds have recently bought and sold shares of the business. Boussard & Gavaudan Investment Management LLP grew its position in Constellium by 79.9% during the fourth quarter. Boussard & Gavaudan Investment Management LLP now owns 2,719,822 shares of the industrial products company’s stock valued at $30,054,000 after acquiring an additional 1,207,612 shares during the period. Evermore Global Advisors LLC grew its position in Constellium by 28.7% during the fourth quarter. Evermore Global Advisors LLC now owns 2,533,103 shares of the industrial products company’s stock valued at $28,244,000 after acquiring an additional 565,248 shares during the period. Rubric Capital Management LP grew its position in Constellium by 2.8% during the third quarter. Rubric Capital Management LP now owns 1,135,116 shares of the industrial products company’s stock valued at $11,635,000 after acquiring an additional 30,422 shares during the period. California Public Employees Retirement System grew its position in Constellium by 2.2% during the second quarter. California Public Employees Retirement System now owns 722,400 shares of the industrial products company’s stock valued at $4,985,000 after acquiring an additional 15,700 shares during the period. Finally, Ecofin Ltd. grew its position in Constellium by 1.7% during the second quarter. Ecofin Ltd. now owns 647,101 shares of the industrial products company’s stock valued at $4,465,000 after acquiring an additional 10,905 shares during the period. 55.99% of the stock is owned by hedge funds and other institutional investors.
Shares of Constellium (NYSE CSTM) opened at $13.05 on Friday. Constellium has a 1 year low of $5.35 and a 1 year high of $13.70. The company has a debt-to-equity ratio of -4.43, a quick ratio of 0.70 and a current ratio of 1.24. The stock has a market capitalization of $1,760.00, a PE ratio of 39.55 and a beta of 0.67.
Constellium Company Profile
Constellium N.V. is a Netherlands-based company engaged in developing aluminum products for a range of markets and applications, including aerospace, automotive and packaging. The Company’s manufacturing facilities are located in the United States, Europe and China. It operates through three segments: Packaging & Automotive Rolled Product; Aerospace & Transportation, and Automotive Structures & Industry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.